APA

Genovese M. C., Bojin S., Biagini I. M., Mociran E., Cristei D., Mirea G., Georgescu L. & Sloan-Lancaster J. (20130522). Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. : Arthritis and rheumatism.

Chicago

Genovese M C, Bojin S, Biagini I M, Mociran E, Cristei D, Mirea G, Georgescu L and Sloan-Lancaster J. 20130522. Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. : Arthritis and rheumatism.

Harvard

Genovese M. C., Bojin S., Biagini I. M., Mociran E., Cristei D., Mirea G., Georgescu L. and Sloan-Lancaster J. (20130522). Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. : Arthritis and rheumatism.

MLA

Genovese M C, Bojin S, Biagini I M, Mociran E, Cristei D, Mirea G, Georgescu L and Sloan-Lancaster J. Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. : Arthritis and rheumatism. 20130522.